Found 0 matching trials
Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65
PHASE2The investigators select 500 subjects who meet the standard and are conside...
Location
Jurong Province Centers for Disease Control and Prevention
Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.
PHASE1The purpose of this study is to test the safety and immunogenicity of MTBVA...
Location
Centre Hospitalier Universitaire Vaudois
Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10
PHASE2Choose healthy subjects and patients with TB, distribute them into differen...
Location
Multiple Locations
ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
N/AThe aim of the study is to pilot the application of a novel ESAT6/CFP10 (C-...
Location
S.H. Ho Research Centre for Infectious Diseases
Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen
PHASE3720 cases TB (Tuberculosis patients) participants、360 cases non-TB particip...
Location
Wuxi NO.5 People's Hospital
Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers
NAThe aim of this study is to test the recombinant tuberculosis skin test in ...
Location
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Clinical Study of BCG Vaccine for Intradermal Injection
PHASE1The study used a randomized, dose-escalation, blinded, placebo-controlled t...
Location
Sichuan Center for Disease Control and Prevention